Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsay M LaFave

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nature Genetics|October 30, 2013
Mining the epigenetic landscape in ALLLindsay M Lafave, Ross L Levine
Nature Medicine|January 7, 2016
Targeting a regulator of protein homeostasis in myeloproliferative neoplasmsLindsay M LaFave, Ross L Levine
Nature Cancer|February 5, 2022
Unlocking PDAC initiation with AP-1Lindsay M LaFave, Jason D Buenrostro
Trends in Pharmacological Sciences|September 22, 2012
JAK2 the future: therapeutic strategies for JAK-dependent malignanciesLindsay M LaFave, Ross L Levine
Cell|March 31, 2023
Research vision workshopping: Peer mentoring to support the transition to independenceN Sumru Bayin, Kara L McKinley, Lindsay M LaFave
STAR Protocols|June 18, 2021
Protocol for single-cell ATAC sequencing using combinatorial indexing in mouse lung adenocarcinomaIsabella Del Priore, Sai Ma, Jonathan Strecker, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Senescent fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticityJin Young Lee, Nabora Reyes, Sang-Ho Woo, et al.
Blood|August 14, 2014
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesisSara C Meyer, Matthew D Keller, Brittany A Woods, et al.
NPJ Precision Oncology|April 8, 2026
High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRAS<sup>G12D</sup> colorectal cancerNatalie Thielen, Ning Wei, Emiko Nagai, et al.
British Journal of Cancer|September 2, 2025
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiationHuizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nature Genetics|October 30, 2013
Mining the epigenetic landscape in ALLLindsay M Lafave, Ross L Levine
Nature Medicine|January 7, 2016
Targeting a regulator of protein homeostasis in myeloproliferative neoplasmsLindsay M LaFave, Ross L Levine
Nature Cancer|February 5, 2022
Unlocking PDAC initiation with AP-1Lindsay M LaFave, Jason D Buenrostro
Trends in Pharmacological Sciences|September 22, 2012
JAK2 the future: therapeutic strategies for JAK-dependent malignanciesLindsay M LaFave, Ross L Levine
Cell|March 31, 2023
Research vision workshopping: Peer mentoring to support the transition to independenceN Sumru Bayin, Kara L McKinley, Lindsay M LaFave
STAR Protocols|June 18, 2021
Protocol for single-cell ATAC sequencing using combinatorial indexing in mouse lung adenocarcinomaIsabella Del Priore, Sai Ma, Jonathan Strecker, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Senescent fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticityJin Young Lee, Nabora Reyes, Sang-Ho Woo, et al.
Blood|August 14, 2014
Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesisSara C Meyer, Matthew D Keller, Brittany A Woods, et al.
NPJ Precision Oncology|April 8, 2026
High-throughput screening identifies NT-1 that synergizes with MRTX1133 against acquired resistant KRAS<sup>G12D</sup> colorectal cancerNatalie Thielen, Ning Wei, Emiko Nagai, et al.
British Journal of Cancer|September 2, 2025
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiationHuizhi Liang, Outhiriaradjou Benard, Viney Kumar, et al.
Pageof 3